News
A new analysis of clinical trial participation in the largest ongoing observational study of U.S. heart attack patients has found participants are not representative of the larger patient base, according to a study led by Women’s College Hospital cardiologist Jay Udell.
September 05, 2014
News
AirStrip, a provider of mobile healthcare applications, has raised $25 million in a strategic funding round led by the Gary & Mary West Health Investment Fund, Sequoia Capital and Wellcome Trust that includes some of the most influential leaders in healthcare.
September 05, 2014
Feature
September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-expanding valve and 14 French equivalent delivery system offers new capabilities that advance valve performance and deliverability during the procedure, while providing the option to recapture and reposition the valve during deployment phase if needed.
September 04, 2014Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
September 4, 2014 — St. Jude Medical announced a new multicenter clinical trial has found that using the company’s fractional flow reserve (FFR) technology changed the course of treatment for more than one-fifth of patients suffering non-ST segment elevation myocardial infarction (NSTEMI) heart attacks.
September 04, 2014
News
The Cardiovascular Cell Therapy Research Network (CCTRN), has selected Cytori Therapeutics, Inc. to supply adipose-derived regenerative cells (ADRCs) for a clinical trial aimed at evaluating the safety and feasibility of treating patients with Left Ventricular Assist Devices (LVADs).
September 04, 2014
Feature
For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one – and placed it just outside the heart.
September 04, 2014Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Dave Fornell
Angiographic imaging system vendors have developed several new technologies to address emerging cath lab trends, including the need to reduce radiation dose, improve image quality and enable advanced procedural image guidance. All three of these points have become increasingly important as more complex procedures are attempted in interventional cardiology cath labs and hybrid ORs. These procedures include transcatheter aortic valve replacement (TAVR), mitral clip valve repairs, left atrial appendage (LAA) occlusions, atrial and ventricular septal defect closures, and new interventions for both electrophysiology (EP) and heart failure.
September 03, 2014
Feature | Stents Bioresorbable | Dave Fornell
A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC) meetings is that bioresorbable stents will eventually replace conventional metallic stents in the coming years. Experts say dissolving stents have their drawbacks compared to metallic stents, but as the technology continues to advance, these issues may be resolved. Even if they are not, experts say growing clinical data shows the benefits of bioresorbable stents may outweigh any drawbacks.
September 03, 2014News
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me of a race between vendors to build a better mouse trap. The main issue between cardiac echo, computed tomography (CT), magnetic resonance imaging (MRI), nuclear (SPECT and PET) and invasive angiography is that each has its strengths and weaknesses.
September 03, 2014Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
In patients who experienced an acute coronary syndrome (ACS) event, use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 did not reduce the risk of recurrent major coronary events.
September 03, 2014
Technology
CorMatrix Cardiovascular announced that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix CanGaroo ECM Envelope for use with cardiac implantable electronic devices (CIED’s) including pacemakers and implantable cardioverter defibrillators (ICD’s).
September 03, 2014
News
September 3, 2014 — Jobst Vascular Institute is conducting pioneering research that looks at using stents to treat blocked veins. The Cook Medical VIVO clinical research study aims to determine the safety and effectiveness of the Zilver vena venous self-expanding stent in the treatment of vein obstructions.
September 03, 2014Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
September 3, 2014 — Teleflex announced a newly published clinical study demonstrating the accuracy of the Arrow VPS G4 vascular positioning system, with placements of peripherally inserted central catheters (PICCs), can eliminate the use of confirmatory chest X-rays.
September 03, 2014
Technology
The easy-to-use online resource mHealth Roadmap includes information on implementation guidelines for mobile and mHealth strategies and applications. Topics covered in the Healthcare Information and Management Systems Society (HIMSS) mHealth Roadmap include:
September 03, 2014
News
Philips has launched Affiniti. The new ultrasound system made its debut at the European Society of Cardiology (ESC) Congress 2014 in Barcelona.
September 02, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now